Document text
Principal Investigator: Kari C. Nadeau
Organization: STANFORD UNIVERSITY
Fiscal Year: 2022
Award: $309,746
Funding agency: National Institute of Allergy and Infectious Diseases
1 ABSTRACT – Clinical Core
2 The Clinical Core of the Stanford HIPC U19 will provide state-of-the-art clinical and biospecimen support for all
3 the research projects, the Immune Monitoring and the Data Management and Analysis Cores, as well as the
4 expertise, facilities, personnel, procedures and processes for the implementation and conduct of the proposed
5 clinical projects. The Clinical Core will provide and update processes and training for clinical investigators and
6 staff; organize, implement, monitor and work to improve clinical project performance; and conduct quality control
7 and corrective action and handle protocol deviations (if needed), including assuring adherence to milestones,
8 project performance expectations, standardized approach in the recruitment and clinical characterization,
9 appropriate human subject protection measures and clinical Good Practice Guidelines. The Clinical Core will
10 provide the clinical research units which include the infrastructure for longitudinal studies: recruitment, retention,
11 data entry and data management, quality review, sample collection (blood, fine needle aspiration (FNA) and
12 bone marrow (BM) aspirates) processing, isolation and cataloging of various specimen types and will oversee
13 all regulatory-related documents and IRB compliant research. The Clinical Core will coordinate clinical
14 biospecimen storage informatics, connecting clinical, biospecimen management, and assay pipelines into a
15 cutting-edge search engine and analysis platform for clinical and translational research. The Clinical Core will
16 be led by Dr. Kari Nadeau with Associate Director Dr. Nadine Rouphael, Dr. Long at UCSF, and Drs. Madhi and
17 Nunez at hospitals in S. Africa. The Clinical Core will work closely with the other cores and projects to enable
18 the functional analysis of any samples with cutting-edge technologies. Drs. Nadeau, Rouphael, Long, Madhi,
19 and Nunez and their teams have the expertise to be able to comprehensively serve as the Clinical Core
20 personnel since they have been successful in other NIH related consortium studies, in performing Clinical Core
21 duties for other immunology clinical studies, and have worked with Drs. Pulendran, Davis, Maecker, Khatri and
22 Boyd for over 15 years. The Core Leader will represent the HIPC center in a HIPC Clinical Sub-Committee that
23 will operate under the HIPC Coordinating Center to promote cross-HIPC collaboration including sharing SOPs,
24 documents, and samples as appropriate. The Clinical Core proposes the following aims: (1) To perform clinical
25 studies with COVID-19 vaccines, and on the impact of the microbiome on rabies vaccination, to provide clinical
26 data and samples to accomplish the scientific goals of the research projects; (2) Establish and maintain
27 personnel training, procedures, and processes to provide core clinical support; and (3) Establish and maintain
28 protocol milestones, performance guidelines, communication strategies, and compliance in clinical studies and
29 sample collection. In summary, the Clinical Core will leverage state-of-the-art biospecimen support services and
30 will coordinate all operational and regulatory aspects of research for the HIPC U19 projects.
31
Terms: <2019-nCoV vaccine><21+ years old><Ablation><Address><Adherence><Adjuvant><Adult><Adult Human><Africa><Algorithms><Allergic Disease><Allergic Reaction><Antibiotic Agents><Antibiotic Drugs><Antibiotics><Antigens><Aspirate><Aspirate substance><Assay><Automobile Driving><Award><B blood cells><B cell><B cells><B-Cells><B-Lymphocytes><B-cell><BNT 162b2><BNT162b2><Bio-Informatics><Bioassay><Bioinformatics><Biologic Assays><Biological Assay><Biological Markers><Blood><Blood Plasma><Blood Reticuloendothelial System><Bone Marrow><Bone Marrow Reticuloendothelial System><COVID-19 vaccine><COVID19 vaccine><Cataloging><Cell Body><Cells><Clinical><Clinical Immunology><Clinical Investigator><Clinical Research><Clinical Study><Clinical Trials><Collaborations><Communication><Computer Models><Computerized Models><Cytometry><Data><Data Analyses><Data Analysis><Data Bases><Data Security><Data Storage and Retrieval><Data awareness><Databases><Development><Ensure><Exposure to><FNA><Fine Needle Aspirate><Fine needle aspiration biopsy><Fine-Needle Aspiration><GCP standard><Goals><Good Clinical Practice><Grippe><Guidelines><Hospitals><Human><Human Resources><IRB><IRBs><Immune><Immune Monitoring><Immune response><Immunes><Immunity><Immunologic Monitoring><Immunological Monitoring><Immunological response><Immunology><Immunomonitoring><Individual><Influenza><Influenza Vaccines><Informatics><Infrastructure><Innate Immunity><Institutional Review Boards><Investigation><Investigators><Longitudinal Studies><Manpower><Measures><Messenger RNA><Miscellaneous Antibiotic><Modern Man><Molecular Fingerprinting><Molecular Profiling><Monitor><NIAID><NIH><National Institute of Allergy and Infectious Disease><National Institutes of Health><Native Immunity><Natural Immunity><Nature><Non-Specific Immunity><Nonspecific Immunity><Performance><Pfizer-BioNTech COVID-19 vaccine><Pfizer-BioNTech coronavirus disease 2019 vaccine><Plasma><Plasma Serum><Population><Practice Guidelines><Predisposition><Procedures><Process><Protocol><Protocols documentation><Quality Control><R-Series Research Projects><R01 Mechanism><R01 Program><RNA vaccine><RNA-based vaccine><Rabies><Recombinants><Reporting><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Specimen><Researchers><Reticuloendothelial System, Serum, Plasma><Role><SARS-CoV-2 vaccine><SARS-CoV2 vaccine><SARS-coronavirus-2 vaccine><Sampling><Saponins><Services><Severe Acute Respiratory Syndrome CoV 2 vaccine><Severe acute respiratory syndrome coronavirus 2 vaccine><South African><Special Population><Specimen><Standardization><Susceptibility><System><T cell response><T-cell receptor repertoire><TCR repertoire><Technology><Time><Training><Translational Research><Translational Science><United States National Institutes of Health><Update><Vaccination><Vaccines><Validation><Work><adaptive immunity><adulthood><antigen-specific T cells><base><bio-markers><biologic marker><biological systems><biomarker><computational modeling><computational models><computer based models><computerized modeling><corona virus disease 2019 vaccine><coronavirus disease 2019 vaccine><coronavirus disease-19 vaccine><cytokine><data base><data deposition><data integration><data interpretation><data management><data retrieval><data storage><data submission><develop a vaccine><develop vaccines><development of a vaccine><developmental><driving><epigenomics><expectation><flu vaccine><flu virus vaccine><host response><human subject><human subject protection><immune system response><immunogen><immunoresponse><improved><influenza virus vaccine><information security><long-term study><longitudinal outcome studies><longterm study><lyssa><mRNA><mRNA vaccine><mRNA-based vaccine><metabolism measurement><metabolomics><metabonomics><microbial consortia><microbial flora><microbiome><microbiota><microflora><molecular profile><molecular signature><multiomics><multiple omics><multispecies consortia><new technology><novel><novel technologies><personnel><public data base><public database><publicly accessible data base><publicly accessible database><publicly available data base><publicly available database><recruit><response><sample collection><search engine><seasonal flu><seasonal influenza><single cell analysis><social role><specimen collection><transcriptomics><translation research><vaccine against 2019-nCov><vaccine against SARS-CoV-2><vaccine against SARS-CoV2><vaccine against SARS-coronavirus-2><vaccine against Severe Acute Respiratory Syndrome CoV 2><vaccine against Severe acute respiratory syndrome coronavirus 2><vaccine against flu><vaccine against influenza><vaccine development><vaccine for novel coronavirus><vaccinology>